Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
26
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Papp Timothy M. | Chief Financial Officer | 13 | $0 | $0 | 2025-09-11 |
| Robertson Judith J. | Director | 20 | $220.8K | $0 | 2025-09-11 |
| Farfel Gail M | Director | 22 | $39.9K | $0 | 2025-09-11 |
| Maderis Gail J | Director | 17 | $135.2K | $0 | 2025-09-11 |
| Sussman Norman | Chief Medical Officer | 14 | $0 | $9.5K | 2025-09-11 |
| AZAB MOHAMMAD | Director | 20 | $23.9K | $0 | 2025-09-11 |
| GARCIA PETER S | Director | 10 | $0 | $0 | 2025-09-11 |
| BROWN JAMES E | President & CEO | 92 | $74.6K | $0 | 2025-09-11 |
| ASEN R SCOTT | 10% Owner | 3 | $398.5K | $0 | 2025-08-22 |
| Blaschke Terrence F | Director | 21 | $4.1K | $0 | 2024-09-25 |
| Bleichroeder LP | 10% Owner | 6 | $382.2K | $518.5K | 2023-03-13 |
| Joice Judy R | Sr. VP Operations & Corp QA | 35 | $0 | $245.1K | 2023-02-21 |
| HOFFMANN DAVE | Director | 33 | $270.3K | $0 | 2022-06-15 |
| Arenberg Michael | Chief Financial Officer | 10 | $8.0K | $0 | 2022-01-06 |
| BENITO SIMON X | Director | 19 | $92.8K | $0 | 2021-12-07 |
| Neukermans Armand | Director | 92 | $90.3K | $0 | 2020-06-17 |
| SAXE JON S | Director | 117 | $114.2K | $0 | 2020-06-17 |
| First Eagle Holdings, Inc. | 10% Owner | 4 | $110.3K | $0 | 2019-09-01 |
| First Eagle Value in Biotechnology Master Fund, Ltd. | 10% Owner | 8 | $11.79M | $0 | 2019-06-20 |
| HOGAN MATTHEW J | Chief Financial Officer | 27 | $0 | $0 | 2018-01-26 |
| THEEUWES FELIX | Chairman and CSO | 157 | $2.83M | $0 | 2018-01-26 |
| 21 APRIL FUND, L.P. | 10% Owner | 6 | $4.99M | $0 | 2016-09-26 |
| Shepard Jay | Director | 7 | $0 | $0 | 2016-06-22 |
| YUM SU IL | Exec. VP Pharm./R&D | 20 | $0 | $0 | 2015-01-09 |
| CASEY MICHAEL D | Director | 3 | $0 | $0 | 2013-06-25 |
| Mendenhall Paula V | Exec. VP of Operations/Admin. | 3 | $0 | $0 | 2012-02-03 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Papp Timothy M. | Chief Financial Officer | D To issuer deriv | 2025-09-11 | 2025-09-12 | 60,000 | — | $0 | 0 | SEC↗ |
| Papp Timothy M. | Chief Financial Officer | D To issuer deriv | 2025-09-11 | 2025-09-12 | 12,377 | — | $0 | 0 | SEC↗ |
| Papp Timothy M. | Chief Financial Officer | D To issuer deriv | 2025-09-11 | 2025-09-12 | 60,000 | — | $0 | 0 | SEC↗ |
| AZAB MOHAMMAD | Director | D To issuer deriv | 2025-09-11 | 2025-09-12 | 5,500 | — | $0 | 0 | SEC↗ |
| AZAB MOHAMMAD | Director | D To issuer deriv | 2025-09-11 | 2025-09-12 | 5,500 | — | $0 | 0 | SEC↗ |
| AZAB MOHAMMAD | Director | D To issuer deriv | 2025-09-11 | 2025-09-12 | 5,500 | — | $0 | 0 | SEC↗ |
| AZAB MOHAMMAD | Director | D To issuer deriv | 2025-09-11 | 2025-09-12 | 2,750 | — | $0 | 0 | SEC↗ |
| AZAB MOHAMMAD | Director | D To issuer deriv | 2025-09-11 | 2025-09-12 | 7,000 | — | $0 | 0 | SEC↗ |
| GARCIA PETER S | Director | D To issuer deriv | 2025-09-11 | 2025-09-12 | 5,500 | — | $0 | 0 | SEC↗ |
| GARCIA PETER S | Director | D To issuer deriv | 2025-09-11 | 2025-09-12 | 5,500 | — | $0 | 0 | SEC↗ |
| GARCIA PETER S | Director | D To issuer deriv | 2025-09-11 | 2025-09-12 | 7,000 | — | $0 | 0 | SEC↗ |
| Farfel Gail M | Director | D To issuer deriv | 2025-09-11 | 2025-09-12 | 5,500 | — | $0 | 0 | SEC↗ |
| Farfel Gail M | Director | D To issuer deriv | 2025-09-11 | 2025-09-12 | 7,000 | — | $0 | 0 | SEC↗ |
| Farfel Gail M | Director | D To issuer deriv | 2025-09-11 | 2025-09-12 | 5,500 | — | $0 | 0 | SEC↗ |
| Farfel Gail M | Director | D To issuer deriv | 2025-09-11 | 2025-09-12 | 5,500 | — | $0 | 0 | SEC↗ |
| Farfel Gail M | Director | D To issuer deriv | 2025-09-11 | 2025-09-12 | 5,500 | — | $0 | 0 | SEC↗ |
| Sussman Norman | Chief Medical Officer | D To issuer deriv | 2025-09-11 | 2025-09-12 | 10,000 | — | $0 | 0 | SEC↗ |
| Sussman Norman | Chief Medical Officer | D To issuer deriv | 2025-09-11 | 2025-09-12 | 20,000 | — | $0 | 0 | SEC↗ |
| Sussman Norman | Chief Medical Officer | D To issuer deriv | 2025-09-11 | 2025-09-12 | 39,837 | — | $0 | 0 | SEC↗ |
| Sussman Norman | Chief Medical Officer | D To issuer deriv | 2025-09-11 | 2025-09-12 | 69,557 | — | $0 | 0 | SEC↗ |
| Sussman Norman | Chief Medical Officer | D To issuer deriv | 2025-09-11 | 2025-09-12 | 104,000 | — | $0 | 0 | SEC↗ |
| Maderis Gail J | Director | D To issuer deriv | 2025-09-11 | 2025-09-12 | 5,500 | — | $0 | 0 | SEC↗ |
| Maderis Gail J | Director | D To issuer deriv | 2025-09-11 | 2025-09-12 | 5,500 | — | $0 | 0 | SEC↗ |
| Maderis Gail J | Director | D To issuer deriv | 2025-09-11 | 2025-09-12 | 2,750 | — | $0 | 0 | SEC↗ |
| Maderis Gail J | Director | D To issuer deriv | 2025-09-11 | 2025-09-12 | 7,000 | — | $0 | 0 | SEC↗ |
| BROWN JAMES E | President & CEO | D To issuer deriv | 2025-09-11 | 2025-09-12 | 103,077 | — | $0 | 0 | SEC↗ |
| BROWN JAMES E | President & CEO | D To issuer deriv | 2025-09-11 | 2025-09-12 | 43,821 | — | $0 | 0 | SEC↗ |
| BROWN JAMES E | President & CEO | D To issuer deriv | 2025-09-11 | 2025-09-12 | 37,175 | — | $0 | 0 | SEC↗ |
| BROWN JAMES E | President & CEO | D To issuer deriv | 2025-09-11 | 2025-09-12 | 36,720 | — | $0 | 0 | SEC↗ |
| BROWN JAMES E | President & CEO | D To issuer deriv | 2025-09-11 | 2025-09-12 | 4,807 | — | $0 | 0 | SEC↗ |
| BROWN JAMES E | President & CEO | D To issuer deriv | 2025-09-11 | 2025-09-12 | 4,717 | — | $0 | 0 | SEC↗ |
| BROWN JAMES E | President & CEO | D To issuer deriv | 2025-09-11 | 2025-09-12 | 250,665 | — | $0 | 0 | SEC↗ |
| BROWN JAMES E | President & CEO | D To issuer deriv | 2025-09-11 | 2025-09-12 | 95,610 | — | $0 | 0 | SEC↗ |
| BROWN JAMES E | President & CEO | D To issuer deriv | 2025-09-11 | 2025-09-12 | 20,900 | — | $0 | 0 | SEC↗ |
| BROWN JAMES E | President & CEO | D To issuer deriv | 2025-09-11 | 2025-09-12 | 22,500 | — | $0 | 0 | SEC↗ |
| BROWN JAMES E | President & CEO | D To issuer deriv | 2025-09-11 | 2025-09-12 | 37,067 | — | $0 | 0 | SEC↗ |
| Robertson Judith J. | Director | D To issuer deriv | 2025-09-11 | 2025-09-12 | 5,500 | — | $0 | 0 | SEC↗ |
| Robertson Judith J. | Director | D To issuer deriv | 2025-09-11 | 2025-09-12 | 5,500 | — | $0 | 0 | SEC↗ |
| Robertson Judith J. | Director | D To issuer deriv | 2025-09-11 | 2025-09-12 | 5,500 | — | $0 | 0 | SEC↗ |
| Robertson Judith J. | Director | D To issuer deriv | 2025-09-11 | 2025-09-12 | 5,500 | — | $0 | 0 | SEC↗ |
| Robertson Judith J. | Director | D To issuer deriv | 2025-09-11 | 2025-09-12 | 7,000 | — | $0 | 0 | SEC↗ |
| BROWN JAMES E | President & CEO | D To issuer deriv | 2025-09-11 | 2025-09-16 | 103,077 | — | $0 | 0 | SEC↗ |
| Papp Timothy M. | Chief Financial Officer | D To issuer | 2025-09-11 | 2025-09-12 | 46,659 | — | $0 | 0 | SEC↗ |
| Papp Timothy M. | Chief Financial Officer | U Tender | 2025-09-11 | 2025-09-12 | 385,000 | — | $0 | 0 | SEC↗ |
| AZAB MOHAMMAD | Director | U Tender | 2025-09-11 | 2025-09-12 | 6,000 | — | $0 | 0 | SEC↗ |
| GARCIA PETER S | Director | U Tender | 2025-09-11 | 2025-09-12 | 12,500 | — | $0 | 0 | SEC↗ |
| Farfel Gail M | Director | U Tender | 2025-09-11 | 2025-09-12 | 15,500 | — | $0 | 0 | SEC↗ |
| Sussman Norman | Chief Medical Officer | D To issuer | 2025-09-11 | 2025-09-12 | 46,425 | — | $0 | 0 | SEC↗ |
| Maderis Gail J | Director | U Tender | 2025-09-11 | 2025-09-12 | 20,000 | — | $0 | 0 | SEC↗ |
| Maderis Gail J | Director | U Tender | 2025-09-11 | 2025-09-12 | 5,500 | — | $0 | 0 | SEC↗ |
| BROWN JAMES E | President & CEO | U Tender | 2025-09-11 | 2025-09-12 | 448,376 | — | $0 | 0 | SEC↗ |
| BROWN JAMES E | President & CEO | U Tender | 2025-09-11 | 2025-09-12 | 8,000 | — | $0 | 0 | SEC↗ |
| BROWN JAMES E | President & CEO | D To issuer | 2025-09-11 | 2025-09-12 | 96,959 | — | $0 | 0 | SEC↗ |
| Robertson Judith J. | Director | U Tender | 2025-09-11 | 2025-09-12 | 41,113 | — | $0 | 0 | SEC↗ |
| Robertson Judith J. | Director | M Exercise deriv | 2025-09-10 | 2025-09-11 | 5,500 | — | $0 | 0 | SEC↗ |
| BROWN JAMES E | President & CEO | M Exercise deriv | 2025-09-10 | 2025-09-11 | 130,000 | — | $0 | 103,077 | SEC↗ |
| Farfel Gail M | Director | M Exercise deriv | 2025-09-10 | 2025-09-11 | 5,500 | — | $0 | 0 | SEC↗ |
| Robertson Judith J. | Director | M Exercise | 2025-09-10 | 2025-09-11 | 5,500 | $1.22 | $6.7K | 41,113 | SEC↗ |
| BROWN JAMES E | President & CEO | M Exercise | 2025-09-10 | 2025-09-11 | 130,000 | $1.30 | $169.0K | 545,335 | SEC↗ |
| Farfel Gail M | Director | M Exercise | 2025-09-10 | 2025-09-11 | 5,500 | $1.22 | $6.7K | 15,500 | SEC↗ |
| Maderis Gail J | Director | M Exercise deriv | 2025-09-09 | 2025-09-11 | 5,500 | — | $0 | 0 | SEC↗ |
| GARCIA PETER S | Director | M Exercise deriv | 2025-09-09 | 2025-09-11 | 5,500 | — | $0 | 0 | SEC↗ |
| BROWN JAMES E | President & CEO | M Exercise deriv | 2025-09-09 | 2025-09-11 | 131,923 | — | $0 | 233,077 | SEC↗ |
| Maderis Gail J | Director | M Exercise | 2025-09-09 | 2025-09-11 | 5,500 | $1.22 | $6.7K | 5,500 | SEC↗ |
| GARCIA PETER S | Director | M Exercise | 2025-09-09 | 2025-09-11 | 5,500 | $1.22 | $6.7K | 12,500 | SEC↗ |
| BROWN JAMES E | President & CEO | M Exercise | 2025-09-09 | 2025-09-11 | 131,923 | $1.30 | $171.5K | 415,335 | SEC↗ |
| Papp Timothy M. | Chief Financial Officer | M Exercise deriv | 2025-09-08 | 2025-09-09 | 110,000 | — | $0 | 0 | SEC↗ |
| BROWN JAMES E | President & CEO | M Exercise deriv | 2025-09-08 | 2025-09-10 | 10,000 | — | $0 | 365,000 | SEC↗ |
| Papp Timothy M. | Chief Financial Officer | M Exercise | 2025-09-08 | 2025-09-09 | 110,000 | $1.30 | $143.0K | 431,659 | SEC↗ |
| BROWN JAMES E | President & CEO | M Exercise | 2025-09-08 | 2025-09-10 | 10,000 | $1.30 | $13.0K | 283,412 | SEC↗ |
| ASEN R SCOTT | 10% Owner | P Buy | 2025-08-22 | 2025-08-26 | 5,917 | $1.92 | $11.4K | 2,672,529 | SEC↗ |
| ASEN R SCOTT | 10% Owner | P Buy | 2025-08-21 | 2025-08-22 | 116,612 | $1.90 | $221.6K | 2,666,612 | SEC↗ |
| ASEN R SCOTT | 10% Owner | P Buy | 2025-08-20 | 2025-08-22 | 87,608 | $1.89 | $165.6K | 970,000 | SEC↗ |
| Papp Timothy M. | Chief Financial Officer | A Award | 2025-07-11 | 2025-07-15 | 46,659 | — | $0 | 321,659 | SEC↗ |
| Sussman Norman | Chief Medical Officer | A Award | 2025-07-11 | 2025-07-15 | 46,425 | — | $0 | 46,425 | SEC↗ |
| BROWN JAMES E | President & CEO | A Award | 2025-07-11 | 2025-07-15 | 96,959 | — | $0 | 273,412 | SEC↗ |
| BROWN JAMES E | President & CEO | A Award deriv | 2024-10-14 | 2024-10-16 | 375,000 | — | $0 | 375,000 | SEC↗ |
| Papp Timothy M. | Chief Financial Officer | A Award deriv | 2024-10-14 | 2024-10-16 | 110,000 | — | $0 | 110,000 | SEC↗ |
| Sussman Norman | Chief Medical Officer | A Award deriv | 2024-10-14 | 2024-10-16 | 104,000 | — | $0 | 104,000 | SEC↗ |
| AZAB MOHAMMAD | Director | A Award deriv | 2024-09-25 | 2024-09-27 | 5,500 | — | $0 | 5,500 | SEC↗ |
| Blaschke Terrence F | Director | A Award deriv | 2024-09-25 | 2024-09-27 | 5,500 | — | $0 | 5,500 | SEC↗ |
| Farfel Gail M | Director | A Award deriv | 2024-09-25 | 2024-09-27 | 5,500 | — | $0 | 5,500 | SEC↗ |
| GARCIA PETER S | Director | A Award deriv | 2024-09-25 | 2024-09-27 | 5,500 | — | $0 | 5,500 | SEC↗ |
| Maderis Gail J | Director | A Award deriv | 2024-09-25 | 2024-09-27 | 5,500 | — | $0 | 5,500 | SEC↗ |
| Robertson Judith J. | Director | A Award deriv | 2024-09-25 | 2024-09-27 | 5,500 | — | $0 | 5,500 | SEC↗ |
| Papp Timothy M. | Chief Financial Officer | A Award | 2024-07-26 | 2024-07-30 | 275,000 | — | $0 | 275,000 | SEC↗ |
| AZAB MOHAMMAD | Director | A Award deriv | 2023-06-21 | 2023-06-23 | 5,500 | — | $0 | 5,500 | SEC↗ |
| Blaschke Terrence F | Director | A Award deriv | 2023-06-21 | 2023-06-23 | 5,500 | — | $0 | 5,500 | SEC↗ |
| Farfel Gail M | Director | A Award deriv | 2023-06-21 | 2023-06-23 | 5,500 | — | $0 | 5,500 | SEC↗ |
| GARCIA PETER S | Director | A Award deriv | 2023-06-21 | 2023-06-23 | 5,500 | — | $0 | 5,500 | SEC↗ |
| Maderis Gail J | Director | A Award deriv | 2023-06-21 | 2023-06-23 | 5,500 | — | $0 | 5,500 | SEC↗ |
| Robertson Judith J. | Director | A Award deriv | 2023-06-21 | 2023-06-23 | 5,500 | — | $0 | 5,500 | SEC↗ |
| BROWN JAMES E | President & CEO | G Gift | 2023-06-12 | 2024-08-06 | 56,000 | — | $0 | 0 | SEC↗ |
| Bleichroeder LP | 10% Owner | J Other | 2023-03-13 | 2023-03-15 | 3,498 | — | $0 | 2,637,965 | SEC↗ |
| BROWN JAMES E | President & CEO | A Award deriv | 2023-02-21 | 2023-02-23 | 50,665 | — | $0 | 50,665 | SEC↗ |
| BROWN JAMES E | President & CEO | A Award deriv | 2023-02-21 | 2023-02-23 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Joice Judy R | Sr. VP Operations & Corp QA | A Award deriv | 2023-02-21 | 2023-02-23 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Joice Judy R | Sr. VP Operations & Corp QA | A Award deriv | 2023-02-21 | 2023-02-23 | 17,456 | — | $0 | 17,456 | SEC↗ |
| Papp Timothy M. | Chief Financial Officer | A Award deriv | 2023-02-21 | 2023-02-23 | 12,377 | — | $0 | 12,377 | SEC↗ |
| Papp Timothy M. | Chief Financial Officer | A Award deriv | 2023-02-21 | 2023-02-23 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Sussman Norman | Chief Medical Officer | A Award deriv | 2023-02-21 | 2023-02-23 | 24,557 | — | $0 | 24,557 | SEC↗ |
| Sussman Norman | Chief Medical Officer | A Award deriv | 2023-02-21 | 2023-02-23 | 45,000 | — | $0 | 45,000 | SEC↗ |
| Robertson Judith J. | Director | P Buy | 2022-08-19 | 2022-08-22 | 9,412 | $0.85 | $8.0K | 356,132 | SEC↗ |
| Robertson Judith J. | Director | P Buy | 2022-08-18 | 2022-08-22 | 71,531 | $0.85 | $60.8K | 346,720 | SEC↗ |
| Robertson Judith J. | Director | P Buy | 2022-08-17 | 2022-08-19 | 8,130 | $0.85 | $6.9K | 275,189 | SEC↗ |
| Robertson Judith J. | Director | P Buy | 2022-08-17 | 2022-08-19 | 2,059 | $0.83 | $1.7K | 267,059 | SEC↗ |
| Maderis Gail J | Director | P Buy | 2022-08-12 | 2022-08-12 | 25,204 | $0.71 | $17.9K | 200,000 | SEC↗ |
| Maderis Gail J | Director | P Buy | 2022-08-11 | 2022-08-11 | 24,796 | $0.70 | $17.4K | 174,796 | SEC↗ |
| Maderis Gail J | Director | P Buy | 2022-08-10 | 2022-08-11 | 79,693 | $0.69 | $55.0K | 150,000 | SEC↗ |
| Maderis Gail J | Director | P Buy | 2022-08-09 | 2022-08-11 | 70,307 | $0.64 | $45.0K | 70,307 | SEC↗ |
| Papp Timothy M. | Chief Financial Officer | A Award deriv | 2022-07-01 | 2022-07-05 | 600,000 | — | $0 | 600,000 | SEC↗ |
| AZAB MOHAMMAD | Director | A Award deriv | 2022-06-15 | 2022-06-17 | 55,000 | — | $0 | 55,000 | SEC↗ |
| Blaschke Terrence F | Director | A Award deriv | 2022-06-15 | 2022-06-17 | 55,000 | — | $0 | 55,000 | SEC↗ |
| Farfel Gail M | Director | A Award deriv | 2022-06-15 | 2022-06-17 | 55,000 | — | $0 | 55,000 | SEC↗ |
| GARCIA PETER S | Director | A Award deriv | 2022-06-15 | 2022-06-17 | 55,000 | — | $0 | 55,000 | SEC↗ |
| HOFFMANN DAVE | Director | A Award deriv | 2022-06-15 | 2022-06-17 | 55,000 | — | $0 | 55,000 | SEC↗ |
| Maderis Gail J | Director | A Award deriv | 2022-06-15 | 2022-06-17 | 55,000 | — | $0 | 55,000 | SEC↗ |
| Robertson Judith J. | Director | A Award deriv | 2022-06-15 | 2022-06-17 | 55,000 | — | $0 | 55,000 | SEC↗ |
| Robertson Judith J. | Director | P Buy | 2022-05-26 | 2022-05-27 | 65,000 | $0.39 | $25.4K | 265,000 | SEC↗ |
| AZAB MOHAMMAD | Director | P Buy | 2022-05-24 | 2022-05-25 | 10,000 | $0.39 | $3.9K | 55,000 | SEC↗ |
| AZAB MOHAMMAD | Director | P Buy | 2022-05-24 | 2022-05-25 | 5,000 | $0.39 | $1.9K | 35,000 | SEC↗ |
| AZAB MOHAMMAD | Director | P Buy | 2022-05-24 | 2022-05-25 | 5,000 | $0.39 | $1.9K | 40,000 | SEC↗ |
| AZAB MOHAMMAD | Director | P Buy | 2022-05-24 | 2022-05-25 | 5,000 | $0.38 | $1.9K | 45,000 | SEC↗ |
| AZAB MOHAMMAD | Director | P Buy | 2022-05-24 | 2022-05-25 | 5,000 | $0.39 | $1.9K | 60,000 | SEC↗ |
| Farfel Gail M | Director | P Buy | 2022-05-18 | 2022-05-18 | 29,911 | $0.41 | $12.3K | 100,000 | SEC↗ |
| AZAB MOHAMMAD | Director | P Buy | 2022-05-17 | 2022-05-18 | 8,900 | $0.42 | $3.7K | 28,200 | SEC↗ |
| AZAB MOHAMMAD | Director | P Buy | 2022-05-17 | 2022-05-18 | 1,800 | $0.42 | $756 | 30,000 | SEC↗ |
| AZAB MOHAMMAD | Director | P Buy | 2022-05-17 | 2022-05-18 | 9,300 | $0.42 | $3.9K | 19,300 | SEC↗ |
| AZAB MOHAMMAD | Director | P Buy | 2022-05-16 | 2022-05-18 | 10,000 | $0.38 | $3.8K | 10,000 | SEC↗ |
| Farfel Gail M | Director | P Buy | 2022-05-16 | 2022-05-18 | 25,300 | $0.39 | $9.9K | 70,089 | SEC↗ |
| Farfel Gail M | Director | P Buy | 2022-05-13 | 2022-05-13 | 9,250 | $0.40 | $3.7K | 44,789 | SEC↗ |
| Farfel Gail M | Director | P Buy | 2022-05-12 | 2022-05-13 | 1,500 | $0.39 | $585 | 35,539 | SEC↗ |
| Farfel Gail M | Director | P Buy | 2022-05-11 | 2022-05-13 | 9,950 | $0.40 | $4.0K | 34,039 | SEC↗ |
| Farfel Gail M | Director | P Buy | 2022-05-10 | 2022-05-10 | 4,250 | $0.40 | $1.7K | 21,750 | SEC↗ |
| Farfel Gail M | Director | P Buy | 2022-05-10 | 2022-05-12 | 2,339 | $0.41 | $959 | 24,089 | SEC↗ |
| Farfel Gail M | Director | P Buy | 2022-05-09 | 2022-05-10 | 17,500 | $0.39 | $6.8K | 17,500 | SEC↗ |
| Robertson Judith J. | Director | P Buy | 2022-03-14 | 2022-03-16 | 200,000 | $0.59 | $118.0K | 200,000 | SEC↗ |
| Arenberg Michael | Chief Financial Officer | A Award deriv | 2022-01-06 | 2022-01-10 | 546,350 | — | $0 | 546,350 | SEC↗ |
| BROWN JAMES E | President & CEO | A Award deriv | 2022-01-06 | 2022-01-10 | 956,110 | — | $0 | 956,110 | SEC↗ |
| Joice Judy R | Sr. VP Operations & Corp QA | A Award deriv | 2022-01-06 | 2022-01-10 | 398,380 | — | $0 | 398,380 | SEC↗ |
| Sussman Norman | Chief Medical Officer | A Award deriv | 2022-01-06 | 2022-01-10 | 398,380 | — | $0 | 398,380 | SEC↗ |
| GARCIA PETER S | Director | A Award deriv | 2021-12-13 | 2021-12-14 | 70,000 | — | $0 | 70,000 | SEC↗ |
| Sussman Norman | Chief Medical Officer | S Sale | 2021-12-10 | 2024-09-11 | 9,000 | $1.06 | $9.5K | 0 | SEC↗ |
| BENITO SIMON X | Director | P Buy | 2021-12-07 | 2021-12-09 | 20,000 | $1.02 | $20.4K | 105,000 | SEC↗ |
| AZAB MOHAMMAD | Director | A Award deriv | 2021-06-15 | 2021-06-16 | 27,500 | — | $0 | 27,500 | SEC↗ |
| BENITO SIMON X | Director | A Award deriv | 2021-06-15 | 2021-06-16 | 55,000 | — | $0 | 55,000 | SEC↗ |
| Blaschke Terrence F | Director | A Award deriv | 2021-06-15 | 2021-06-16 | 55,000 | — | $0 | 55,000 | SEC↗ |
| Farfel Gail M | Director | A Award deriv | 2021-06-15 | 2021-06-16 | 55,000 | — | $0 | 55,000 | SEC↗ |
| HOFFMANN DAVE | Director | A Award deriv | 2021-06-15 | 2021-06-16 | 55,000 | — | $0 | 55,000 | SEC↗ |
| Maderis Gail J | Director | A Award deriv | 2021-06-15 | 2021-06-16 | 27,500 | — | $0 | 27,500 | SEC↗ |
| Robertson Judith J. | Director | A Award deriv | 2021-06-15 | 2021-06-16 | 55,000 | — | $0 | 55,000 | SEC↗ |
| Joice Judy R | Sr. VP Operations & Corp QA | M Exercise deriv | 2021-05-14 | 2021-05-17 | 20,000 | — | $0 | 0 | SEC↗ |
| Joice Judy R | Sr. VP Operations & Corp QA | M Exercise deriv | 2021-05-14 | 2021-05-17 | 40,137 | — | $0 | 0 | SEC↗ |
| Joice Judy R | Sr. VP Operations & Corp QA | S Sale | 2021-05-14 | 2021-05-17 | 60,137 | $1.72 | $103.4K | 34,832 | SEC↗ |
| Joice Judy R | Sr. VP Operations & Corp QA | M Exercise | 2021-05-14 | 2021-05-17 | 20,000 | $0.73 | $14.6K | 54,832 | SEC↗ |
| Joice Judy R | Sr. VP Operations & Corp QA | M Exercise | 2021-05-14 | 2021-05-17 | 40,137 | $0.78 | $31.3K | 94,969 | SEC↗ |
| Arenberg Michael | Chief Financial Officer | A Award deriv | 2021-01-15 | 2021-01-19 | 116,000 | — | $0 | 116,000 | SEC↗ |
| BROWN JAMES E | President & CEO | A Award deriv | 2021-01-15 | 2021-01-19 | 209,000 | — | $0 | 209,000 | SEC↗ |
| Joice Judy R | Sr. VP Operations & Corp QA | A Award deriv | 2021-01-15 | 2021-01-19 | 79,000 | — | $0 | 79,000 | SEC↗ |
| Sussman Norman | Chief Medical Officer | A Award deriv | 2021-01-15 | 2021-01-19 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Maderis Gail J | Director | A Award deriv | 2021-01-04 | 2021-01-05 | 70,000 | — | $0 | 70,000 | SEC↗ |
| AZAB MOHAMMAD | Director | A Award deriv | 2021-01-04 | 2021-01-05 | 70,000 | — | $0 | 70,000 | SEC↗ |
| Sussman Norman | Chief Medical Officer | A Award deriv | 2020-11-02 | 2020-11-04 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Bleichroeder LP | 10% Owner | S Sale | 2020-09-01 | 2020-09-02 | 250,000 | $1.68 | $420.0K | 26,414,656 | SEC↗ |
| Farfel Gail M | Director | A Award deriv | 2020-06-17 | 2020-06-18 | 55,000 | — | $0 | 55,000 | SEC↗ |
| BENITO SIMON X | Director | A Award deriv | 2020-06-17 | 2020-06-18 | 55,000 | — | $0 | 55,000 | SEC↗ |
| Neukermans Armand | Director | A Award deriv | 2020-06-17 | 2020-06-18 | 55,000 | — | $0 | 55,000 | SEC↗ |
| SAXE JON S | Director | A Award deriv | 2020-06-17 | 2020-06-18 | 55,000 | — | $0 | 55,000 | SEC↗ |
| Blaschke Terrence F | Director | A Award deriv | 2020-06-17 | 2020-06-18 | 55,000 | — | $0 | 55,000 | SEC↗ |
| HOFFMANN DAVE | Director | A Award deriv | 2020-06-17 | 2020-06-18 | 55,000 | — | $0 | 55,000 | SEC↗ |
| Robertson Judith J. | Director | A Award deriv | 2020-06-17 | 2020-06-19 | 55,000 | — | $0 | 55,000 | SEC↗ |
| Joice Judy R | Sr. VP Operations & Corp QA | M Exercise deriv | 2020-06-03 | 2020-06-05 | 34,864 | — | $0 | 22,956 | SEC↗ |
| Joice Judy R | Sr. VP Operations & Corp QA | M Exercise deriv | 2020-06-03 | 2020-06-05 | 22,956 | — | $0 | 0 | SEC↗ |
| Joice Judy R | Sr. VP Operations & Corp QA | S Sale | 2020-06-03 | 2020-06-05 | 22,956 | $2.45 | $56.2K | 32,747 | SEC↗ |
| Joice Judy R | Sr. VP Operations & Corp QA | M Exercise | 2020-06-03 | 2020-06-05 | 34,864 | $0.78 | $27.2K | 67,611 | SEC↗ |
| Joice Judy R | Sr. VP Operations & Corp QA | M Exercise | 2020-06-03 | 2020-06-05 | 22,956 | $0.78 | $17.9K | 55,703 | SEC↗ |
| Joice Judy R | Sr. VP Operations & Corp QA | S Sale | 2020-06-03 | 2020-06-05 | 34,864 | $2.45 | $85.4K | 32,747 | SEC↗ |
| Bleichroeder LP | 10% Owner | S Sale | 2020-05-26 | 2020-05-28 | 39,388 | $2.50 | $98.5K | 26,664,656 | SEC↗ |
| Bleichroeder LP | 10% Owner | P Buy | 2020-02-06 | 2020-02-06 | 75,000 | $1.65 | $123.8K | 26,704,044 | SEC↗ |
| Bleichroeder LP | 10% Owner | P Buy | 2020-02-05 | 2020-02-06 | 74,998 | $1.69 | $126.7K | 26,629,044 | SEC↗ |
| Bleichroeder LP | 10% Owner | P Buy | 2020-02-04 | 2020-02-06 | 77,500 | $1.70 | $131.8K | 26,554,046 | SEC↗ |
| BROWN JAMES E | President & CEO | A Award deriv | 2020-01-21 | 2020-01-23 | 138,145 | — | $0 | 138,145 | SEC↗ |
| BROWN JAMES E | President & CEO | A Award deriv | 2020-01-21 | 2020-01-23 | 86,855 | — | $0 | 86,855 | SEC↗ |
| Joice Judy R | Sr. VP Operations & Corp QA | A Award deriv | 2020-01-21 | 2020-01-23 | 82,278 | — | $0 | 82,278 | SEC↗ |
| Joice Judy R | Sr. VP Operations & Corp QA | A Award deriv | 2020-01-21 | 2020-01-23 | 2,722 | — | $0 | 2,722 | SEC↗ |
| Arenberg Michael | Chief Financial Officer | A Award deriv | 2020-01-21 | 2020-01-23 | 101,764 | — | $0 | 101,764 | SEC↗ |
| Arenberg Michael | Chief Financial Officer | A Award deriv | 2020-01-21 | 2020-01-23 | 23,236 | — | $0 | 23,236 | SEC↗ |
| First Eagle Holdings, Inc. | 10% Owner | J Other | 2019-09-01 | 2019-09-04 | 26,476,546 | — | $0 | 0 | SEC↗ |
| First Eagle Value in Biotechno | 10% Owner | P Buy | 2019-06-20 | 2019-06-24 | 4,000,000 | $0.52 | $2.08M | 26,476,546 | SEC↗ |
| BENITO SIMON X | Director | A Award deriv | 2019-06-19 | 2019-06-20 | 55,000 | — | $0 | 55,000 | SEC↗ |
| Blaschke Terrence F | Director | A Award deriv | 2019-06-19 | 2019-06-20 | 55,000 | — | $0 | 55,000 | SEC↗ |
| HOFFMANN DAVE | Director | A Award deriv | 2019-06-19 | 2019-06-20 | 55,000 | — | $0 | 55,000 | SEC↗ |
| Neukermans Armand | Director | A Award deriv | 2019-06-19 | 2019-06-20 | 55,000 | — | $0 | 55,000 | SEC↗ |
| SAXE JON S | Director | A Award deriv | 2019-06-19 | 2019-06-20 | 55,000 | — | $0 | 55,000 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-06-10 | 2019-06-11 | 1,200 | $0.54 | $648 | 126,487 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-06-10 | 2019-06-11 | 287 | $0.54 | $155 | 125,287 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-06-10 | 2019-06-11 | 200 | $0.54 | $108 | 126,687 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-06-10 | 2019-06-11 | 15 | $0.54 | $8 | 126,702 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-06-10 | 2019-06-11 | 300 | $0.54 | $162 | 127,002 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-06-10 | 2019-06-11 | 100 | $0.54 | $54 | 127,102 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-06-10 | 2019-06-11 | 7,898 | $0.54 | $4.3K | 135,000 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-06-10 | 2019-06-11 | 100 | $0.55 | $55 | 135,100 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-06-10 | 2019-06-11 | 1,751 | $0.55 | $963 | 136,851 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-06-10 | 2019-06-11 | 300 | $0.55 | $165 | 137,151 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-06-10 | 2019-06-11 | 1,400 | $0.55 | $770 | 138,551 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-06-10 | 2019-06-11 | 500 | $0.55 | $275 | 139,051 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-06-10 | 2019-06-11 | 300 | $0.55 | $165 | 139,351 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-06-10 | 2019-06-11 | 1,800 | $0.55 | $990 | 141,151 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-06-10 | 2019-06-11 | 400 | $0.55 | $220 | 141,551 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-06-10 | 2019-06-11 | 1,400 | $0.55 | $770 | 142,951 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-06-10 | 2019-06-11 | 3,449 | $0.56 | $1.9K | 146,400 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-06-10 | 2019-06-11 | 626 | $0.56 | $351 | 147,026 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-06-10 | 2019-06-11 | 74 | $0.56 | $41 | 147,100 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-06-10 | 2019-06-11 | 2,900 | $0.56 | $1.6K | 150,000 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-05-24 | 2019-05-28 | 4,065 | $0.63 | $2.6K | 99,065 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-05-24 | 2019-05-28 | 4,600 | $0.63 | $2.9K | 125,000 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-05-24 | 2019-05-28 | 21,335 | $0.63 | $13.4K | 120,400 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-05-13 | 2019-05-14 | 864 | $0.70 | $605 | 69,954 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-05-13 | 2019-05-14 | 1,584 | $0.70 | $1.1K | 69,090 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-05-13 | 2019-05-14 | 1,391 | $0.70 | $974 | 67,506 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-05-13 | 2019-05-14 | 595 | $0.70 | $417 | 66,115 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-05-13 | 2019-05-14 | 300 | $0.70 | $210 | 65,520 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-05-13 | 2019-05-14 | 4,900 | $0.70 | $3.4K | 65,220 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-05-13 | 2019-05-14 | 1,232 | $0.70 | $862 | 60,320 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-05-13 | 2019-05-14 | 1,000 | $0.69 | $690 | 59,088 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-05-13 | 2019-05-14 | 400 | $0.69 | $276 | 58,088 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-05-13 | 2019-05-14 | 895 | $0.69 | $618 | 57,688 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-05-13 | 2019-05-14 | 779 | $0.69 | $538 | 56,793 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-05-13 | 2019-05-14 | 569 | $0.69 | $393 | 56,014 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-05-13 | 2019-05-14 | 489 | $0.69 | $337 | 55,445 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-05-13 | 2019-05-14 | 1,195 | $0.69 | $825 | 54,956 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-05-13 | 2019-05-14 | 3,100 | $0.69 | $2.1K | 53,761 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-05-13 | 2019-05-14 | 200 | $0.69 | $138 | 50,661 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-05-13 | 2019-05-14 | 699 | $0.69 | $482 | 50,461 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-05-13 | 2019-05-14 | 900 | $0.68 | $612 | 49,762 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-05-13 | 2019-05-14 | 287 | $0.68 | $195 | 48,862 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-05-13 | 2019-05-14 | 2,995 | $0.68 | $2.0K | 48,575 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-05-13 | 2019-05-14 | 380 | $0.68 | $258 | 45,580 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-05-13 | 2019-05-14 | 200 | $0.68 | $136 | 45,200 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-05-13 | 2019-05-14 | 800 | $0.70 | $560 | 85,400 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-05-13 | 2019-05-14 | 2,085 | $0.70 | $1.5K | 84,600 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-05-13 | 2019-05-14 | 400 | $0.70 | $280 | 70,354 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-05-13 | 2019-05-14 | 4,826 | $0.70 | $3.4K | 75,180 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-05-13 | 2019-05-14 | 1,600 | $0.70 | $1.1K | 76,780 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-05-13 | 2019-05-14 | 1,798 | $0.70 | $1.3K | 78,578 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-05-13 | 2019-05-14 | 37 | $0.70 | $26 | 82,515 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-05-13 | 2019-05-14 | 3,900 | $0.70 | $2.7K | 82,478 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-05-13 | 2019-05-15 | 900 | $0.70 | $630 | 86,300 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-05-13 | 2019-05-15 | 6,500 | $0.70 | $4.5K | 92,800 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-05-13 | 2019-05-15 | 2,200 | $0.71 | $1.6K | 95,000 | SEC↗ |
| Robertson Judith J. | Director | A Award deriv | 2019-04-23 | 2019-04-25 | 70,000 | — | $0 | 70,000 | SEC↗ |
| Farfel Gail M | Director | A Award deriv | 2019-04-23 | 2019-04-25 | 70,000 | — | $0 | 70,000 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-03-13 | 2019-03-15 | 1,200 | $0.82 | $984 | 25,986 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-03-13 | 2019-03-15 | 100 | $0.82 | $82 | 24,286 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-03-13 | 2019-03-15 | 100 | $0.82 | $82 | 24,186 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-03-13 | 2019-03-15 | 386 | $0.82 | $317 | 24,086 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-03-13 | 2019-03-15 | 2,400 | $0.82 | $2.0K | 23,700 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-03-13 | 2019-03-15 | 100 | $0.82 | $82 | 21,300 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-03-13 | 2019-03-15 | 100 | $0.82 | $82 | 21,200 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-03-13 | 2019-03-15 | 500 | $0.82 | $410 | 21,100 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-03-13 | 2019-03-15 | 200 | $0.82 | $164 | 20,600 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-03-13 | 2019-03-15 | 400 | $0.83 | $332 | 20,400 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-03-13 | 2019-03-15 | 600 | $0.82 | $492 | 41,300 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-03-13 | 2019-03-15 | 300 | $0.82 | $246 | 40,700 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-03-13 | 2019-03-15 | 600 | $0.82 | $492 | 40,400 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-03-13 | 2019-03-15 | 200 | $0.82 | $164 | 39,800 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-03-13 | 2019-03-15 | 625 | $0.82 | $513 | 39,600 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-03-13 | 2019-03-15 | 600 | $0.82 | $492 | 38,975 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-03-13 | 2019-03-15 | 200 | $0.82 | $164 | 38,375 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-03-13 | 2019-03-15 | 100 | $0.82 | $82 | 38,175 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-03-13 | 2019-03-15 | 400 | $0.82 | $328 | 38,075 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-03-13 | 2019-03-15 | 300 | $0.82 | $246 | 37,675 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-03-13 | 2019-03-15 | 3,441 | $0.82 | $2.8K | 37,375 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-03-13 | 2019-03-15 | 4,600 | $0.82 | $3.8K | 33,934 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-03-13 | 2019-03-15 | 748 | $0.82 | $613 | 29,334 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-03-13 | 2019-03-15 | 200 | $0.82 | $164 | 28,586 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-03-13 | 2019-03-15 | 100 | $0.82 | $82 | 28,386 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-03-13 | 2019-03-15 | 1,800 | $0.82 | $1.5K | 28,286 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-03-13 | 2019-03-15 | 200 | $0.82 | $164 | 26,486 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-03-13 | 2019-03-15 | 300 | $0.82 | $246 | 26,286 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-03-13 | 2019-03-15 | 100 | $0.82 | $82 | 24,386 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-03-13 | 2019-03-15 | 400 | $0.82 | $328 | 24,786 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-03-13 | 2019-03-15 | 200 | $0.82 | $164 | 43,400 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-03-13 | 2019-03-15 | 200 | $0.82 | $164 | 44,600 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-03-13 | 2019-03-15 | 200 | $0.82 | $164 | 44,400 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-03-13 | 2019-03-15 | 600 | $0.82 | $492 | 44,200 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-03-13 | 2019-03-15 | 100 | $0.82 | $82 | 43,600 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-03-13 | 2019-03-15 | 100 | $0.82 | $82 | 43,500 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-03-13 | 2019-03-15 | 300 | $0.82 | $246 | 44,900 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-03-13 | 2019-03-15 | 800 | $0.82 | $656 | 43,200 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-03-13 | 2019-03-15 | 100 | $0.82 | $82 | 42,400 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-03-13 | 2019-03-15 | 100 | $0.82 | $82 | 42,300 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-03-13 | 2019-03-15 | 900 | $0.82 | $738 | 42,200 | SEC↗ |
| SAXE JON S | Director | P Buy | 2019-03-13 | 2019-03-15 | 100 | $0.82 | $82 | 45,000 | SEC↗ |
| Arenberg Michael | Chief Financial Officer | P Buy | 2019-03-12 | 2019-03-13 | 10,000 | $0.80 | $8.0K | 24,426 | SEC↗ |
| Arenberg Michael | Chief Financial Officer | A Award deriv | 2019-01-23 | 2019-01-25 | 89,375 | — | $0 | 89,375 | SEC↗ |
| Arenberg Michael | Chief Financial Officer | A Award deriv | 2019-01-23 | 2019-01-25 | 20,625 | — | $0 | 106,960 | SEC↗ |
| Arenberg Michael | Chief Financial Officer | A Award deriv | 2019-01-23 | 2019-01-25 | 86,335 | — | $0 | 86,335 | SEC↗ |
| BROWN JAMES E | President & CEO | A Award deriv | 2019-01-23 | 2019-01-25 | 53,947 | — | $0 | 53,947 | SEC↗ |
| BROWN JAMES E | President & CEO | A Award deriv | 2019-01-23 | 2019-01-25 | 221,755 | — | $0 | 221,755 | SEC↗ |